quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:48:19·1190d
NEWSRelease
Alcoa Corporation logo
AIM ImmunoTech Inc. logo
Berkshire Grey Inc. logo
+15

Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

AA· Alcoa CorporationAIM· AIM ImmunoTech Inc.BGRY· Berkshire Grey Inc.BVXV· BiondVax Pharmaceuticals Ltd.CVAC· CureVac N.V.DCPH· Deciphera Pharmaceuticals Inc.
IndustrialsHealth CareFinance
Original source

Companies

  • AA
    Alcoa Corporation
    Industrials
  • AIM
    AIM ImmunoTech Inc.
    Health Care
  • BGRY
    Berkshire Grey Inc.
    Industrials
  • BVXV
    BiondVax Pharmaceuticals Ltd.
    Health Care
  • CVAC
    CureVac N.V.
    Health Care
  • DCPH
    Deciphera Pharmaceuticals Inc.
    Health Care
  • HGEN
    Humanigen Inc.
    Health Care
  • HUDI
    Huadi International Group Co. Ltd.
    Industrials
  • MEGL
    Magic Empire Global Limited
    Finance
  • OLK
    Olink Holding AB
    Industrials
  • OTRK
    Ontrak Inc.
    Health Care
  • RNAZ
    TransCode Therapeutics Inc.
    Health Care
  • SGTX
    Sigilon Therapeutics Inc.
    Health Care
  • TCBP
    TC BioPharm (Holdings) plc
    Health Care
  • TCDA
    Tricida Inc.
    Health Care
  • VAPO
    Vapotherm Inc.
    Health Care
  • VRE
    Veris Residential Inc.
    Real Estate
  • ZYME
    Zymeworks Inc.
    Health Care

Recent analyst ratings

  • Apr 9AAUpdateMorgan Stanley$80.00
  • Mar 13AAUpdateAnalyst$68.00
  • Jan 27AAUpdateMorgan Stanley$64.00
  • Jan 13AAUpdateWells Fargo$71.00
  • Jan 8AAUpdateAnalyst$50.00
  • Dec 12ZYMEUpdateWells Fargo$33.00

Related

  • PR2d
    Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
  • SEC3d
    SEC Form SCHEDULE 13G filed by TransCode Therapeutics Inc.
  • INSIDER6d
    SEC Form 4 filed by Olson Emily M.
  • PR6d
    Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
  • SEC7d
    Alcoa Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR7d
    Alcoa Corporation Reports First Quarter 2026 Results
  • PR7d
    AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP
  • PR8d
    Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022